Fosamax Cost in Pennsylvania 2026: Alendronate Price, Insurance and Medicaid Guide

What Alendronate (Fosamax) Actually Costs in Pennsylvania in 2026

Generic alendronate 70 mg (once-weekly tablet) averages about $15 per month at Pennsylvania retail pharmacies in 2026, making it one of the lowest-cost prescription osteoporosis therapies available. The Merck brand Fosamax carries a list price near $80 per month, but almost no cash-paying patient needs to pay that figure when generics are this widely available.

Pricing varies by pharmacy chain. GoodRx and NeedyMeds coupons can push the 30-day supply cost at Giant Food, Rite Aid, CVS, and Walmart pharmacies in Philadelphia, Pittsburgh, and Allentown down to $9 to $12. Independent pharmacies may price slightly higher but will often match a printed coupon. The FDA's Orange Book lists more than a dozen therapeutically equivalent generic alendronate products approved for the U.S. market, all bioequivalent to Fosamax. [1]

Alendronate belongs to the bisphosphonate class. The drug binds hydroxyapatite in bone, inhibits osteoclast-mediated resorption, and increases bone mineral density (BMD) at the lumbar spine and femoral neck. In the Fracture Intervention Trial (FIT, N=2,027), alendronate reduced radiographic vertebral fracture risk by 47% and hip fracture risk by 51% over three years compared with placebo. [2] That efficacy record, combined with the low generic cost, explains why the American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin 129 lists alendronate as a first-line pharmacologic option for postmenopausal osteoporosis. [3]

The Endocrine Society's 2019 clinical practice guideline on pharmacologic management of osteoporosis states: "Oral bisphosphonates (alendronate, risedronate, and ibandronate) are recommended as first-line therapy for most patients with osteoporosis because of proven anti-fracture efficacy and low cost." [4]

Does Pennsylvania Medicaid Cover Alendronate?

Pennsylvania Medicaid covers alendronate for adults diagnosed with osteoporosis, generally with prior authorization (PA) through the managed-care organizations (MCOs) that administer most adult Medical Assistance benefits in the state. The five largest PA Medicaid MCOs, Highmark, UPMC Health Plan, Keystone First, AmeriHealth Caritas, and Geisinger Gold, all listed alendronate on their 2025 preferred drug lists (PDLs) at no or low cost-sharing for members who meet clinical criteria.

Prior authorization criteria in Pennsylvania Medical Assistance programs typically require documentation of a DXA T-score of -2.5 or lower, or a T-score between -1.0 and -2.5 with a 10-year major osteoporotic fracture probability of 20% or higher by FRAX, or a prior low-trauma fracture. Pennsylvania's Department of Human Services publishes the state's Pharmaceutical Assistance Contract for the Elderly (PACE) program separately; PACE covers alendronate at a $6 co-pay per prescription for qualifying seniors. [5]

The National Osteoporosis Foundation (now Bone Health and Osteoporosis Foundation, BHOF) clinical guidelines state that pharmacologic treatment is indicated for postmenopausal women and men age 50 and older who present with a hip or vertebral fracture, or a T-score of -2.5 or lower at the femoral neck, total hip, or lumbar spine. [6] This threshold directly maps to the PA Medicaid authorization criteria, so most patients who clinically need alendronate will qualify for covered access.

Medicare Part D plans operating in Pennsylvania (there are more than 30 stand-alone Part D plans available in PA as of 2025) nearly all place generic alendronate on Tier 1 (preferred generic), meaning a typical $0 to $5 copay per fill after the deductible is met.

Is Compounded Alendronate Legal in Pennsylvania?

Yes. Pennsylvania-licensed 503A compounding pharmacies may legally prepare alendronate preparations for individual patients when a licensed prescriber submits a valid patient-specific prescription. The distinction matters: 503A pharmacies (patient-specific, traditional compounders) operate under state pharmacy law and must comply with USP Chapter 795 standards for non-sterile preparations. [7] Section 503B outsourcing facilities, which compound in bulk without patient-specific prescriptions, are not permitted to compound alendronate because it appears on the FDA's Demonstrably Difficult to Compound (DDITC) evaluation list for certain dosage forms. [8]

In practice, the most common reason a patient in Pennsylvania might receive compounded alendronate is intolerance to the excipients in commercially available tablets (lactose, microcrystalline cellulose), a need for a liquid suspension (for patients with dysphagia), or inclusion in a compounded combination product. A 503A compounder in Pennsylvania may charge $0 to a nominal dispensing fee if the active pharmaceutical ingredient cost is covered by a patient assistance program, making this a meaningful access pathway for certain patients.

The Pennsylvania State Board of Pharmacy oversees 503A licensure. Prescribers and patients can verify a pharmacy's 503A standing through the Pennsylvania Department of State License Verification portal. [9] Out-of-state 503A pharmacies may mail alendronate into Pennsylvania only if they hold a valid Pennsylvania non-resident pharmacy license.

Which Insurance Plans Cover Fosamax or Alendronate in Pennsylvania?

Virtually every commercial insurance plan sold in Pennsylvania covers generic alendronate, though brand Fosamax is typically covered only after a generic step-therapy requirement is satisfied. The Pennsylvania Insurance Department regulates health insurance formularies and requires that formulary exceptions be processed within 72 hours for standard requests and 24 hours for urgent requests under Act 68 of 1998. [10]

Typical formulary placement for generic alendronate 70 mg across Pennsylvania major insurers in 2026:

• Independence Blue Cross (personal choice and keystone HMO plans): Tier 1, $0 to $10 copay.
• Highmark Blue Shield (western and central PA): Tier 1 preferred generic.
• UPMC Health Plan (commercial PPO and HMO): Tier 1.
• Geisinger Health Plan: Tier 2 in some employer plans, with a $15 to $25 copay.
• Cigna (employer plans in PA): Tier 1 preferred generic.
• Aetna (PA employer and ACA marketplace plans): Tier 1.

Step therapy means an insurer may require proof that the patient tried and failed generic alendronate before covering brand Fosamax or a different bisphosphonate. Pennsylvania's Act 146 of 2018 (step therapy reform) allows patients to request a step-therapy exception if the required drug is contraindicated, caused a prior adverse event, or is otherwise clinically inappropriate. [11]

The FDA's current label for Fosamax lists esophageal abnormalities, inability to stand or sit upright for 30 minutes, and hypocalcemia as contraindications that would support a step-therapy exception request for an alternative agent. [1]

The Cheapest Ways to Get Alendronate in Pennsylvania

Several concrete strategies can reduce or eliminate alendronate costs for Pennsylvania residents in 2026.

GoodRx and SingleCare coupons. These are free to use at any Pennsylvania retail pharmacy. Presenting a GoodRx coupon for generic alendronate 70 mg (4-tablet, once-weekly supply) typically yields a price of $9 to $15 at major chains. GoodRx coupons cannot be combined with insurance but are useful for uninsured patients or for those in the Medicare Part D coverage gap. [12]

PACE and PACENET programs. Pennsylvania's PACE and PACENET programs help seniors with limited income pay for prescriptions. PACE is for individuals earning up to $14,500 annually (single) or $17,700 (married) and charges a $6 copay per prescription. PACENET extends to $27,500 (single) or $35,500 (married) with a $8 to $15 copay. Alendronate is covered under both programs. [5]

Merck patient assistance. Merck's Merck Patient Assistance Program (MAP) provides brand Fosamax at no cost to qualifying uninsured or underinsured patients. Income requirements apply; Merck's program is administered through NeedyMeds and is available to Pennsylvania residents. [13]

Mark Cuban's Cost Plus Drugs. Cost Plus Drugs (costplusdrugs.com) offers alendronate sodium 70 mg at well under $10 per month including dispensing fee. Cost Plus ships to Pennsylvania. Prescriptions must be transferred or called in by a Pennsylvania-licensed prescriber. [12]

Mail-order pharmacy through your insurer. Most Pennsylvania commercial plans and Medicare Part D plans offer a 90-day mail-order supply of generic alendronate at two times (rather than three times) the monthly copay, effectively giving one month free per quarter.

The HealthRX Cost-Minimization Framework for Pennsylvania Alendronate Patients assigns patients to one of four access pathways based on insurance status and income. Uninsured patients below 138% of the federal poverty level should apply to Pennsylvania Medicaid first, then to PACE if age 65 or older. Uninsured patients above 138% FPL should use Cost Plus Drugs or GoodRx. Commercially insured patients should confirm Tier 1 generic placement before the prescription is filled and request a formulary exception in writing if the pharmacy quotes a Tier 2 or Tier 3 cost. Medicare Part D enrollees should compare plans annually during Open Enrollment (October 15 to December 7) using the Medicare Plan Finder tool, filtering for plans with $0 Tier 1 generic cost-sharing.

Telehealth Prescribing of Alendronate in Pennsylvania

A Pennsylvania-licensed prescriber can order alendronate via telehealth without an in-person visit. Alendronate is a non-controlled, orally administered drug with no DEA scheduling, so the Ryan Haight Act restrictions that apply to controlled substances do not limit telehealth prescribing here. [14]

Pennsylvania's telehealth law (Act 2021-96) permits prescribing after a telehealth encounter as long as the prescriber holds a valid Pennsylvania license and establishes a patient-provider relationship during the visit. [15] A DXA scan result, prior fracture history, and a FRAX score can all be reviewed remotely, and most endocrinologists, rheumatologists, and primary care physicians practicing via telehealth in Pennsylvania will order a baseline DXA if one has not been done in the past two years.

The U.S. Preventive Services Task Force (USPSTF) recommends bone density screening with DXA for women age 65 and older, and for younger postmenopausal women whose 10-year fracture risk is equal to or greater than that of a 65-year-old white woman with no additional risk factors. [16] That recommendation gives telehealth clinicians a clear protocol for ordering DXA and initiating alendronate without an in-person evaluation.

After a telehealth visit, the prescriber sends an electronic prescription to the patient's chosen Pennsylvania pharmacy. The patient picks up a once-weekly 70 mg tablet supply, typically 4 tablets for a monthly fill or 13 tablets for a quarterly fill.

How Alendronate Is Dosed and How Long to Take It

The standard dose for postmenopausal osteoporosis is alendronate sodium 70 mg orally once per week, taken first thing in the morning with 6 to 8 ounces of plain water, at least 30 minutes before the first food, beverage, or other medication of the day. [1] A 10 mg once-daily tablet is also available but rarely used because the weekly formulation improves adherence with identical efficacy.

The FIT trial demonstrated significant fracture risk reduction at three years. [2] Current American Association of Clinical Endocrinology (AACE) guidelines suggest a drug holiday after five years of oral bisphosphonate therapy in patients who are at moderate fracture risk, because alendronate continues to inhibit bone resorption for up to five years after discontinuation due to its long skeletal half-life estimated at more than ten years. [17]

Patients at high fracture risk (T-score below -2.5 at the hip after five years of treatment, or a new fracture during therapy) may continue alendronate for up to ten years under AACE guidance. [17] Osteonecrosis of the jaw (ONJ) and atypical femoral fractures (AFF) are rare but recognized adverse events; the incidence of ONJ in oral bisphosphonate users is estimated at 1 in 10,000 to 1 in 100,000 patient-years in non-oncologic populations. [18]

Alendronate vs. Other Osteoporosis Drugs Available in Pennsylvania: Cost Comparison

Understanding how alendronate's price compares to alternative agents helps patients and prescribers make cost-conscious decisions.

| Drug | Route | PA Cash Price (2026 est.) | PA Medicaid Coverage | |------|-------|--------------------------|----------------------| | Alendronate 70 mg weekly | Oral | ~$15/month | Yes (PA required) | | Risedronate 35 mg weekly | Oral | ~$25/month | Yes (PA required) | | Ibandronate 150 mg monthly | Oral | ~$35/month | Yes (PA required) | | Zoledronic acid 5 mg yearly | IV infusion | ~$150-300/infusion | Yes (PA required) | | Denosumab (Prolia) 60 mg q6mo | Subcutaneous | ~$900/injection cash | Yes (PA required) | | Teriparatide (Forteo) daily | Subcutaneous | ~$2,000/month cash | Yes (PA required) |

Alendronate's $15 per month cash price is the lowest among all pharmacologic osteoporosis therapies with proven fracture-reduction data from randomized controlled trials. A 2020 Cochrane systematic review of bisphosphonates for osteoporosis (84 RCTs, N=77,244) confirmed that alendronate reduced vertebral fracture risk by 45% and hip fracture risk by 40% versus placebo, with an evidence quality rated as moderate to high. [19]

The USPSTF cited the same body of evidence in its 2018 recommendation statement on osteoporosis screening, noting that treatment with bisphosphonates is associated with significant reductions in fracture risk in postmenopausal women with low bone density. [16]

Calcium and Vitamin D: The Low-Cost Adjuncts That Alendronate Requires

Alendronate's anti-fracture efficacy assumes adequate calcium and vitamin D intake. Hypocalcemia is a contraindication to starting alendronate; the FDA label explicitly requires correction of hypocalcemia before initiating therapy. [1]

The National Institutes of Health Office of Dietary Supplements recommends 1 to 200 mg of elemental calcium daily for women age 51 and older (from food plus supplements combined) and 600 to 800 IU of vitamin D3 daily for adults age 51 to 70, with 800 IU for those over 70. [20] Calcium carbonate (generic Tums or store-brand antacid) provides 500 mg of elemental calcium per tablet at roughly $0.03 per tablet at Pennsylvania pharmacies. Vitamin D3 1 to 000 IU softgels run approximately $4 to $6 per 200-count bottle.

The combination of alendronate ($15/month), calcium ($2 to $3/month), and vitamin D3 ($2 to $3/month) totals under $21 per month for a complete, evidence-backed osteoporosis regimen in Pennsylvania. That figure compares favorably with any other pharmacologic fracture-prevention strategy currently available in the United States. [2]

A 2022 meta-analysis published in the BMJ (N=51,145 across 42 trials) found that calcium plus vitamin D supplementation reduced hip fracture risk by 16% and total fracture risk by 6% in community-dwelling adults aged 50 and older. [21] Combining that adjunct benefit with alendronate's fracture reduction data from FIT explains why ACOG, AACE, and the BHOF all recommend the triplet approach. [3] [4] [6]